RE: NO PLACING...10 Jan 2025 13:08
Extension of Warrants in Incanthera to 31 March 2025
ImmuPharma PLC (LSE: IMM), the specialist drug discovery and development company, is pleased to announce that the Company has agreed with Incanthera plc ("Incanthera") that Warrants issued to the Company on 26 February 2020, in conjunction with Incanthera's IPO onto the Aquis Exchange, are extended by a further period to 31 March 2025.